213 related articles for article (PubMed ID: 18486120)
1. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.
Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):119-24. PubMed ID: 18486120
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Chilukuri N; Duysen EG; Parikh K; diTargiani R; Doctor BP; Lockridge O; Saxena A
Mol Pharmacol; 2009 Sep; 76(3):612-7. PubMed ID: 19542320
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain.
Johnson ND; Duysen EG; Lockridge O
Neurotoxicology; 2009 May; 30(3):386-92. PubMed ID: 19442823
[TBL] [Abstract][Full Text] [Related]
4. Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds.
Parikh K; Duysen EG; Snow B; Jensen NS; Manne V; Lockridge O; Chilukuri N
J Pharmacol Exp Ther; 2011 Apr; 337(1):92-101. PubMed ID: 21205915
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo.
Chilukuri N; Duysen EG; Parikh K; Sun W; Doctor BP; Lockridge O; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):327-31. PubMed ID: 18499092
[TBL] [Abstract][Full Text] [Related]
6. A repeated injection of polyethyleneglycol-conjugated recombinant human butyrylcholinesterase elicits immune response in mice.
Chilukuri N; Sun W; Parikh K; Naik RS; Tang L; Doctor BP; Saxena A
Toxicol Appl Pharmacol; 2008 Sep; 231(3):423-9. PubMed ID: 18586293
[TBL] [Abstract][Full Text] [Related]
7. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
Duysen EG; Bartels CF; Lockridge O
J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
[TBL] [Abstract][Full Text] [Related]
8. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
Li B; Duysen EG; Carlson M; Lockridge O
J Pharmacol Exp Ther; 2008 Mar; 324(3):1146-54. PubMed ID: 18056867
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase.
Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():115-21. PubMed ID: 16253215
[TBL] [Abstract][Full Text] [Related]
12. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
13. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
14. Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase.
Chilukuri N; Sun W; Naik RS; Parikh K; Tang L; Doctor BP; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):255-60. PubMed ID: 18603232
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and immunologic consequences of repeated administrations of purified heterologous and homologous butyrylcholinesterase in mice.
Sun W; Luo C; Naik RS; Doctor BP; Saxena A
Life Sci; 2009 Oct; 85(17-18):657-61. PubMed ID: 19772863
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
18. The butyrylcholinesterase knockout mouse is obese on a high-fat diet.
Li B; Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):88-91. PubMed ID: 18452903
[TBL] [Abstract][Full Text] [Related]
19. Fast affinity purification coupled with mass spectrometry for identifying organophosphate labeled plasma butyrylcholinesterase.
Li H; Tong L; Schopfer LM; Masson P; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):68-72. PubMed ID: 18586231
[TBL] [Abstract][Full Text] [Related]
20. Influence of lipid imbalance on butyrylcholinesterase activity and biotransformation efficiency.
Sisková K; Bilka F; Adameová A; Balazová A; Mydla M; Pauliková I
Pharmazie; 2012 Apr; 67(4):345-50. PubMed ID: 22570941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
